Tower Research Capital (TRC)’s Nutex Health NUTX Stock Holding History
Bought
Maintained
Sold
Other funds holding NUTX
Tower Research Capital (TRC)'s NUTX Position: Q3 2026 in Review
Tower Research Capital (TRC) reduced its Nutex Health (NUTX) stake by 51% in Q3 2026, selling an estimated $61.1K and leaving 321 shares worth $67.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3047.
Tower Research Capital (TRC) first reported a position in NUTX in Q2 2022 and has held it in 16 quarters since. The position peaked at $112K in Q2 2026. 182 funds tracked by Wall St. Rank hold NUTX as of Q3 2026.
- Tower Research Capital (TRC) held 321 shares of Nutex Health worth $67.9K as of Q3 2026.
- Tower Research Capital (TRC) sold 332 Nutex Health shares in Q3 2026, an estimated $61.1K.
- Nutex Health made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #3047 holding.
- Tower Research Capital (TRC) first reported a position in Nutex Health in Q2 2022 and has held it in 16 quarters since.
- Tower Research Capital (TRC)'s Nutex Health position peaked at $112K in Q2 2026.
- 182 funds tracked by Wall St. Rank held Nutex Health as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.